var singsData = [{"date":new Date(2012,10,1),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Needham downgrades JCI to Hold from Buy.","showOnAxis":false},{"date":new Date(2012,10,1),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains JCI to Buy. Target Price is $33; previously $35.","showOnAxis":false},{"date":new Date(2012,11,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains JCI to Hold. Target Price is $29; previously $28.","showOnAxis":false},{"date":new Date(2012,11,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains JCI to Neutral. Target Price is $31; previously $29.","showOnAxis":false},{"date":new Date(2012,11,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains JCI to Hold. Target Price is $30; previously $27.","showOnAxis":false},{"date":new Date(2012,2,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Guggenheim maintains JCI to Buy. Target Price is $41; previously $41.95.","showOnAxis":false},{"date":new Date(2012,3,13),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Deutsche Bank upgrades JCI to Buy from Hold. Target Price is $39; previously $40.","showOnAxis":false},{"date":new Date(2012,3,20),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, JCI reports 2012 Q2's earning $0.55 per share and revenue $10565MM..","showOnAxis":false},{"date":new Date(2012,3,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains JCI to Hold. Target Price is $36; previously $35.","showOnAxis":false},{"date":new Date(2012,3,25),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.12428","showOnAxis":true},{"date":new Date(2012,5,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains JCI to Equal-Weight. Target Price is $37; previously $35.","showOnAxis":false},{"date":new Date(2012,5,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains JCI to Buy. Target Price is $38.5; previously $39.","showOnAxis":false},{"date":new Date(2012,6,16),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains JCI to Neutral. Target Price is $28; previously $30.","showOnAxis":false},{"date":new Date(2012,6,18),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan initiates coverage on JCI to Neutral. Target Price is $36.","showOnAxis":false},{"date":new Date(2012,6,19),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, JCI reports 2012 Q3's earning $0.64 per share and revenue $10580MM. This misses analyst's estimated EPS $0.66, misses estimated revenue $10810MM.","showOnAxis":false},{"date":new Date(2012,6,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Bank of America maintains JCI to Buy. Target Price is $40; previously $44.","showOnAxis":false},{"date":new Date(2012,6,20),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Deutsche Bank downgrades JCI to Hold from Buy. Target Price is $32; previously $35.","showOnAxis":false},{"date":new Date(2012,6,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains JCI to Neutral. Target Price is $33; previously $36.","showOnAxis":false},{"date":new Date(2012,6,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains JCI to Hold. Target Price is $26; previously $28.","showOnAxis":false},{"date":new Date(2012,6,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains JCI to Buy. Target Price is $35; previously $38.","showOnAxis":false},{"date":new Date(2012,6,20),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains JCI to Neutral. Target Price is $27; previously $28.","showOnAxis":false},{"date":new Date(2012,6,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains JCI to Overweight. Target Price is $38; previously $42.","showOnAxis":false},{"date":new Date(2012,6,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Sterne Agee maintains JCI to Neutral. Target Price is $28; previously $35.","showOnAxis":false},{"date":new Date(2012,6,25),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.12428","showOnAxis":true},{"date":new Date(2012,6,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Wunderlich maintains JCI to Buy. Target Price is $45.","showOnAxis":false},{"date":new Date(2012,6,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains JCI to Hold. Target Price is $28; previously $36.","showOnAxis":false},{"date":new Date(2012,6,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains JCI to Buy. Target Price is $38; previously $40.","showOnAxis":false},{"date":new Date(2012,9,1),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0","showOnAxis":true},{"date":new Date(2012,9,12),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.15","showOnAxis":true},{"date":new Date(2012,9,30),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, JCI reports 2012 Q4's earning $-0.07 per share and revenue $10392MM..","showOnAxis":false},{"date":new Date(2012,9,31),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Macquarie downgrades JCI to Neutral from Outperform.","showOnAxis":false},{"date":new Date(2012,9,31),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains JCI to Hold. Target Price is $28.5; previously $32.","showOnAxis":false},{"date":new Date(2012,9,31),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains JCI to Hold. Target Price is $27; previously $26.","showOnAxis":false},{"date":new Date(2012,9,31),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains JCI to Neutral. Target Price is $26; previously $27.","showOnAxis":false},{"date":new Date(2013,0,18),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, JCI reports 2013 Q1's earning $0.52 per share and revenue $10420MM. This beats analyst's estimated EPS $0.51, beats estimated revenue $10240MM.","showOnAxis":false},{"date":new Date(2013,0,22),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Lazard downgrades JCI to Neutral from Buy.","showOnAxis":false},{"date":new Date(2013,0,23),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.15","showOnAxis":true},{"date":new Date(2013,0,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains JCI to Hold. Target Price is $33.5; previously $29.","showOnAxis":false},{"date":new Date(2013,10,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains JCI to Hold. Target Price is $50; previously $48.","showOnAxis":false},{"date":new Date(2013,10,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains JCI to Neutral. Target Price is $50; previously $47.","showOnAxis":false},{"date":new Date(2013,11,10),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"RBC Capital upgrades JCI to Top Pick from Outperform. Target Price is $61.","showOnAxis":false},{"date":new Date(2013,11,12),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Barclays upgrades JCI to Overweight from Equal-weight. Target Price is $64; previously $52.","showOnAxis":false},{"date":new Date(2013,11,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains JCI to Hold. Target Price is $54; previously $55.","showOnAxis":false},{"date":new Date(2013,11,4),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"RBC Capital upgrades JCI to Outperform from Sector Perform. Target Price is $61; previously $45.","showOnAxis":false},{"date":new Date(2013,2,14),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Credit Agricole upgrades JCI to Buy from Outperform. Target Price is $50; previously $36.","showOnAxis":false},{"date":new Date(2013,3,22),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Baird upgrades JCI to Outperform from Neutral.","showOnAxis":false},{"date":new Date(2013,3,23),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Baird upgrades JCI to Outperform from Neutral. Target Price is $44; previously $36.","showOnAxis":false},{"date":new Date(2013,3,23),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, JCI reports 2013 Q2's earning $0.42 per share and revenue $10400MM. This meets analyst's estimated EPS $0.42, misses estimated revenue $10460MM.","showOnAxis":false},{"date":new Date(2013,3,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains JCI to Hold. Target Price is $34; previously $31.","showOnAxis":false},{"date":new Date(2013,3,24),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.16","showOnAxis":true},{"date":new Date(2013,3,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains JCI to Hold. Target Price is $35; previously $34.","showOnAxis":false},{"date":new Date(2013,4,13),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Lazard upgrades JCI to Buy from Neutral.","showOnAxis":false},{"date":new Date(2013,4,28),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Wells Fargo upgrades JCI to Outperform from Neutral.","showOnAxis":false},{"date":new Date(2013,6,18),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, JCI reports 2013 Q3's earning $0.83 per share and revenue $10800MM. This beats analyst's estimated EPS $0.75, misses estimated revenue $10990MM.","showOnAxis":false},{"date":new Date(2013,6,24),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.16","showOnAxis":true},{"date":new Date(2013,8,30),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Morgan Stanley downgrades JCI to Underweight from Overweight. Target Price is $40; previously $45.","showOnAxis":false},{"date":new Date(2013,9,23),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.16","showOnAxis":true},{"date":new Date(2013,9,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains JCI to Hold. Target Price is $55; previously $56.","showOnAxis":false},{"date":new Date(2013,9,29),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, JCI reports 2013 Q4's earning $0.95 per share and revenue $11050MM. This meets analyst's estimated EPS $0.95, beats estimated revenue $10960MM.","showOnAxis":false},{"date":new Date(2013,9,30),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains JCI to Hold. Target Price is $48; previously $46.","showOnAxis":false},{"date":new Date(2014,0,22),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.16","showOnAxis":true},{"date":new Date(2014,0,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains JCI to Neutral. Target Price is $50.","showOnAxis":false},{"date":new Date(2014,0,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains JCI to Hold. Target Price is $54.","showOnAxis":false},{"date":new Date(2014,0,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains JCI to Overweight from Overweight. Target Price is $60; previously $62.","showOnAxis":false},{"date":new Date(2014,1,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"FBR Capital initiates coverage on JCI to Outperform. Target Price is $65.","showOnAxis":false},{"date":new Date(2014,11,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Ascendiant Capital initiates coverage on JCI to Buy. Target Price is $68.","showOnAxis":false},{"date":new Date(2014,11,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains JCI to Neutral. Target Price is $51; previously $50.","showOnAxis":false},{"date":new Date(2014,3,22),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains JCI to Neutral. Target Price is $52; previously $54.","showOnAxis":false},{"date":new Date(2014,3,23),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.18","showOnAxis":true},{"date":new Date(2014,3,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains JCI to Hold. Target Price is $52; previously $54.","showOnAxis":false},{"date":new Date(2014,5,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Susquehanna initiates coverage on JCI to Neutral. Target Price is $57.","showOnAxis":false},{"date":new Date(2014,6,14),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains JCI to Overweight. Target Price is $59; previously $60.","showOnAxis":false},{"date":new Date(2014,6,18),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, JCI reports 2014 Q3's earning $0.84 per share and revenue $10810MM. This beats analyst's estimated EPS $0.83, misses estimated revenue $10820MM.","showOnAxis":false},{"date":new Date(2014,6,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains JCI to Neutral. Target Price is $51; previously $50.","showOnAxis":false},{"date":new Date(2014,6,23),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.18","showOnAxis":true},{"date":new Date(2014,8,22),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains JCI to Neutral. Target Price is $57; previously $51.","showOnAxis":false},{"date":new Date(2014,9,13),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"RBC Capital downgrades JCI to Outperform from Top Pick. Target Price is $49; previously $61.","showOnAxis":false},{"date":new Date(2014,9,14),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Wells Fargo downgrades JCI to Market Perform from Outperform.","showOnAxis":false},{"date":new Date(2014,9,22),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.18","showOnAxis":true},{"date":new Date(2015,0,12),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura initiates coverage on JCI to Neutral. Target Price is $46.","showOnAxis":false},{"date":new Date(2015,0,21),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.18","showOnAxis":true},{"date":new Date(2015,11,11),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains JCI to Overweight. Target Price is $52; previously $54.","showOnAxis":false},{"date":new Date(2015,11,15),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"RBC Capital downgrades JCI to Sector Perform from Outperform.","showOnAxis":false},{"date":new Date(2015,11,2),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"William Blair downgrades JCI to Market Perform from Outperform.","showOnAxis":false},{"date":new Date(2015,2,11),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains JCI to Hold. Target Price is $55; previously $56.","showOnAxis":false},{"date":new Date(2015,2,3),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains JCI to Hold. Target Price is $56; previously $54.","showOnAxis":false},{"date":new Date(2015,3,1),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains JCI to Neutral. Target Price is $55; previously $52.","showOnAxis":false},{"date":new Date(2015,3,22),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.205","showOnAxis":true},{"date":new Date(2015,3,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Nomura maintains JCI to Neutral. Target Price is $50; previously $46.","showOnAxis":false},{"date":new Date(2015,3,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup maintains JCI to Neutral. Target Price is $54; previously $51.","showOnAxis":false},{"date":new Date(2015,4,28),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"UBS upgrades JCI to Buy from Neutral. Target Price is $59; previously $51.","showOnAxis":false},{"date":new Date(2015,5,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Buckingham Research assumes JCI to Buy. Target Price is $63.","showOnAxis":false},{"date":new Date(2015,5,11),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Macquarie maintains JCI to Neutral. Target Price is $54; previously $48.","showOnAxis":false},{"date":new Date(2015,6,22),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.205","showOnAxis":true},{"date":new Date(2015,6,27),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains JCI to Overweight. Target Price is $54; previously $57.","showOnAxis":false},{"date":new Date(2015,7,12),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades JCI to Buy from Neutral.","showOnAxis":false},{"date":new Date(2015,7,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse initiates coverage on JCI to Neutral. Target Price is $49.","showOnAxis":false},{"date":new Date(2015,8,15),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Susquehanna maintains JCI to Neutral. Target Price is $45; previously $52.","showOnAxis":false},{"date":new Date(2015,8,30),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"William Blair upgrades JCI to Outperform from Market Perform. Target Price is $50; previously $53.","showOnAxis":false},{"date":new Date(2015,9,2),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Nomura upgrades JCI to Buy. Target Price is $50; previously $53.","showOnAxis":false},{"date":new Date(2015,9,21),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.205","showOnAxis":true},{"date":new Date(2016,0,20),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.205","showOnAxis":true},{"date":new Date(2016,0,25),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Barclays maintains JCI to Overweight. Target Price is $47; previously $52.","showOnAxis":false},{"date":new Date(2016,0,29),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains JCI to Neutral. Target Price is $44; previously $34.66.","showOnAxis":false},{"date":new Date(2016,0,7),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Oppenheimer initiates coverage on JCI to Outperform. Target Price is $48.","showOnAxis":false},{"date":new Date(2016,10,1),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains JCI to Buy.","showOnAxis":false},{"date":new Date(2016,10,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Citigroup initiates coverage on JCI to Buy. Target Price is $54.","showOnAxis":false},{"date":new Date(2016,10,8),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, JCI reports 2016 Q4's earning $1.21 per share and revenue $10218MM. This beats analyst's estimated EPS $1.01, beats estimated revenue $9510MM.","showOnAxis":false},{"date":new Date(2016,11,12),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2016,3,13),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley assumes JCI to Overweight. Target Price is $47.","showOnAxis":false},{"date":new Date(2016,3,20),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.205","showOnAxis":true},{"date":new Date(2016,3,21),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, JCI reports 2016 Q2's earning $0.86 per share and revenue $9031MM. This beats analyst's estimated EPS $0.82, beats estimated revenue $9020MM.","showOnAxis":false},{"date":new Date(2016,4,24),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Credit Suisse upgrades JCI to Outperform.","showOnAxis":false},{"date":new Date(2016,6,20),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.205","showOnAxis":true},{"date":new Date(2016,6,21),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, JCI reports 2016 Q3's earning $1.07 per share and revenue $9516MM. This beats analyst's estimated EPS $1.03, misses estimated revenue $9620MM.","showOnAxis":false},{"date":new Date(2016,7,1),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains JCI to Overweight. Target Price is $52; previously $50.","showOnAxis":false},{"date":new Date(2016,7,22),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains JCI to Outperform. Target Price is $52.","showOnAxis":false},{"date":new Date(2016,7,23),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains JCI to Outperform. Target Price is $52.","showOnAxis":false},{"date":new Date(2016,7,3),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.23","showOnAxis":true},{"date":new Date(2016,8,16),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Bernstein initiates coverage on JCI to Outperform.","showOnAxis":false},{"date":new Date(2016,8,16),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains JCI to Buy. Target Price is $51; previously $52.","showOnAxis":false},{"date":new Date(2016,8,21),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains JCI to Buy. Target Price is $53; previously $51.","showOnAxis":false},{"date":new Date(2016,8,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Cowen & Co. initiates coverage on JCI to Outperform.","showOnAxis":false},{"date":new Date(2016,8,6),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"RBC Capital assumes JCI to Sector Perform.","showOnAxis":false},{"date":new Date(2016,8,8),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Macquarie maintains JCI to Outperform. Target Price is $55; previously $43.","showOnAxis":false},{"date":new Date(2016,8,9),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Atlantic Equities assumes JCI to Overweight.","showOnAxis":false},{"date":new Date(2016,9,18),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Baird initiates coverage on JCI to Outperform.","showOnAxis":false},{"date":new Date(2016,9,24),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs initiates coverage on JCI to Buy.","showOnAxis":false},{"date":new Date(2017,1,1),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, JCI reports 2017 Q1's earning $0.53 per share and revenue $7096MM. This beats analyst's estimated EPS $0.52, misses estimated revenue $7150MM.","showOnAxis":false}];